ロード中...
CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer
BACKGROUND: Primary chemotherapy (PC) is used for down-staging locally advanced breast cancer (LABC). CA 15-3 measures the protein product of the MUC1 gene and is the most widely used serum marker in breast cancer. METHODS: We retrospectively investigated the role of CA 15-3 in conjunction with othe...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1590047/ https://ncbi.nlm.nih.gov/pubmed/16953875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-220 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|